Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220013629 220008056 1.65 97 Disease modification (D) 2013-07-18 2013-08-25 AML18 PILOT TRIAL null N 220030712 PILOT TRIAL
220013630 220008058 1.78 79 Curative (C) 2017-09-07 2017-09-19 Alemtuz+Fludara+Melphalan RIC MUD null Y 220030713 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013631 220008061 1.65 null null 2015-11-12 2015-11-13 Rituximab N Y 220030717 RITUXIMAB
220013632 220008062 1.8 72.9 Curative (C) 2015-08-10 2015-08-14 AML 18 TRIAL Y N 220030719 AML18 TRIAL
220013633 220008063 1.77 101.4 Palliative (P) 2017-06-22 2017-06-22 Dasatinib N null 220030722 DASATINIB
220013634 220008064 null 97 Curative (C) 2015-07-22 2015-07-22 Rituximab 2 N 220030722 RITUXIMAB
220013635 220008064 1.79 74.2 Curative (C) 2017-10-06 2017-11-18 AML 18 TRIAL 1 N 220030722 AML18 TRIAL
220013636 220008064 1.6 66 Curative (C) 2016-07-27 2016-11-03 AML18 PILOT TRIAL Y Y 220030722 PILOT TRIAL
220013637 220008066 1.59 78.7 Curative (C) 2013-10-03 2013-10-03 Dasatinib 02 N 220030731 DASATINIB
220013638 220008067 1.88 null Curative (C) 2013-04-29 2013-04-29 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220030733 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013639 220008069 1.7 63 Curative (C) 2013-05-31 2013-06-11 Alemtuz+Fludara+Melphalan RIC MUD N N 220030735 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013640 220008071 1.61 null Curative (C) 2016-08-30 2016-09-14 Rituximab N N 220030736 RITUXIMAB
220013641 220017866 null 59.9 Curative (C) 2014-05-13 2014-06-17 AML18 PILOT TRIAL Y null 220030737 PILOT TRIAL
220013642 220008073 1.58 78.7 Disease modification (D) null 2017-02-01 Rituximab N null 220030737 RITUXIMAB
220013643 220008075 1.66 100 null 2014-07-02 2014-07-13 AML 18 TRIAL Y N 220030740 AML18 TRIAL
220013644 220008076 null null Disease modification (D) 2014-03-22 2014-06-22 Rituximab N N 220030743 RITUXIMAB
220013645 220008079 1.63 null Curative (C) 2013-10-27 2013-11-07 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220030748 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013646 220008080 null null Curative (C) 2015-07-01 2015-07-01 Rituximab 02 null 220030753 RITUXIMAB
220013647 220008081 1.88 100.5 null 2014-07-16 2014-10-20 AML 18 TRIAL N N 220030754 AML18 TRIAL
220013648 220008084 0 null Curative (C) 2017-07-14 2017-07-20 Dasatinib 2 N 220030759 DASATINIB
220013651 220008086 0 80.6 Curative (C) 2013-10-13 2013-10-13 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 02 N 220030766 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013652 220008089 1.63 null Curative (C) 2017-04-07 2017-04-08 Dasatinib 2 N 220030766 DASATINIB
220013653 220008089 1.6 54.6 Disease modification (D) 2016-02-20 2016-07-14 Alemtuz+Fludara+Melphalan RIC MUD N null 220030766 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013657 220008090 1.76 81 null 2016-03-03 2016-03-04 Alemtuz+Fludara+Melphalan RIC MUD N N 220030779 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013658 220020925 0 null Palliative (P) 2015-06-11 2015-06-15 Dasatinib N N 220030783 DASATINIB
220013659 220020925 null 58.6 Curative (C) null 2017-06-10 Rituximab N null 220030783 RITUXIMAB
220013660 220008091 1.62 90.4 Curative (C) 2015-09-15 2015-09-24 Alemtuz+Fludara+Melphalan RIC MUD N N 220030784 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013661 220008091 1.79 60.33 null 2013-06-23 2013-06-24 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220030784 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013662 220008091 1.64 null Curative (C) 2014-12-25 2014-12-25 Dasatinib null N 220030784 DASATINIB
220013663 220008092 null 54.7 Curative (C) 2016-08-25 2016-08-25 Alemtuz+Fludara+Melphalan RIC MUD N N 220030801 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013664 220008093 1.67 73.4 Curative (C) 2014-09-05 2014-09-17 AML18 PILOT TRIAL 01 N 220030802 PILOT TRIAL
220013665 220008094 null 0 Adjuvant (A) 2016-07-07 2016-07-09 Rituximab 02 null 220030802 RITUXIMAB
220013666 220008094 1.68 122 Neo-adjuvant (N) 2014-07-13 2015-06-12 Rituximab 2 N 220030802 RITUXIMAB
220013667 220008096 1.73 null Curative (C) 2015-08-31 2015-09-03 Alemtuz+Fludara+Melphalan RIC MUD null null 220030808 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013668 220008097 0 50 null 2017-07-25 2017-07-25 Rituximab N N 220030809 RITUXIMAB
220013670 220008100 1.79 91.1 Curative (C) 2017-01-13 2017-02-26 AML 18 Pilot Trial 01 N 220030811 PILOT TRIAL
220013671 220017871 1.69 81.3 Curative (C) 2016-05-24 2016-05-24 Alemtuz+Fludara+Melphalan RIC MUD N N 220030819 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013672 220008101 0 74.4 Curative (C) 2014-12-09 2015-01-11 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220030820 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013673 220008102 1.63 62 Curative (C) 2016-09-29 2016-11-23 AML18 PILOT TRIAL N N 220030822 PILOT TRIAL
220013674 220008102 1.67 71.2 null 2013-08-26 2013-08-27 AML 18 TRIAL Y N 220030822 AML18 TRIAL
220013675 220017872 1.55 null Adjuvant (A) 2017-08-27 2017-11-12 Dasatinib N N 220030823 DASATINIB
220013676 220017872 1.59 59.7 Curative (C) 2017-09-23 2017-10-11 Alemtuz+Fludara+Melphalan RIC MUD N null 220030823 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013677 220017872 null 80 Curative (C) 2014-04-04 2014-04-14 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220030823 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013678 220008103 1.68 62.5 Curative (C) 2014-03-26 2014-05-11 AML18 PILOT TRIAL Y N 220030837 PILOT TRIAL
220013679 220008104 1.7 95 Curative (C) null 2016-05-16 Alemtuz+Fludara+Melphalan RIC MUD N null 220030840 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013680 220008106 1.84 76.5 Curative (C) 2018-01-03 2018-01-09 Dasatinib N N 220030842 DASATINIB
220013681 220008107 1.66 27.25 Disease modification (D) 2018-08-06 2018-08-06 Rituximab null N 220030847 RITUXIMAB
220013682 220008108 1.58 95.7 Curative (C) null 2013-08-06 AML18 PILOT TRIAL Y null 220030849 PILOT TRIAL
220013683 220008111 1.61 83.3 Curative (C) 2017-09-07 2017-09-10 Dasatinib 02 N 220030858 DASATINIB
220013684 220008112 1.57 65.2 Disease modification (D) 2017-03-01 2017-06-10 Dasatinib 02 N 220030863 DASATINIB